544 related articles for article (PubMed ID: 23619146)
21. Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn's disease.
Yao Y; Feng Q; Shen J
Expert Rev Clin Immunol; 2020 Dec; 16(12):1127-1141. PubMed ID: 33183108
[No Abstract] [Full Text] [Related]
22. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases.
Tao Y; Yue M; Lv C; Yun X; Qiao S; Fang Y; Wei Z; Xia Y; Dai Y
FASEB J; 2020 Feb; 34(2):3069-3090. PubMed ID: 31908053
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model.
Zhao J; Zhao R; Cheng L; Yang J; Zhu L
Dig Liver Dis; 2018 Nov; 50(11):1195-1204. PubMed ID: 29891333
[TBL] [Abstract][Full Text] [Related]
25. Pterostilbene Ameliorates DSS-Induced Intestinal Epithelial Barrier Loss in Mice via Suppression of the NF-κB-Mediated MLCK-MLC Signaling Pathway.
Wang J; Zhao H; Lv K; Zhao W; Zhang N; Yang F; Wen X; Jiang X; Tian J; Liu X; Ho CT; Li S
J Agric Food Chem; 2021 Apr; 69(13):3871-3878. PubMed ID: 33759516
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
Lapointe TK; Buret AG
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation.
Wroblewski LE; Shen L; Ogden S; Romero-Gallo J; Lapierre LA; Israel DA; Turner JR; Peek RM
Gastroenterology; 2009 Jan; 136(1):236-46. PubMed ID: 18996125
[TBL] [Abstract][Full Text] [Related]
28. Numb modulates the paracellular permeability of intestinal epithelial cells through regulating apical junctional complex assembly and myosin light chain phosphorylation.
Yang Y; Chen L; Tian Y; Ye J; Liu Y; Song L; Pan Q; He Y; Chen W; Peng Z; Wang R
Exp Cell Res; 2013 Dec; 319(20):3214-25. PubMed ID: 23872314
[TBL] [Abstract][Full Text] [Related]
29. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis.
Breugelmans T; Van Spaendonk H; De Man JG; De Schepper HU; Jauregui-Amezaga A; Macken E; Lindén SK; Pintelon I; Timmermans JP; De Winter BY; Smet A
J Crohns Colitis; 2020 Jul; 14(7):974-994. PubMed ID: 32003421
[TBL] [Abstract][Full Text] [Related]
30. Dietary protocatechuic acid redistributes tight junction proteins by targeting Rho-associated protein kinase to improve intestinal barrier function.
So BR; Kim S; Jang SH; Kim MJ; Lee JJ; Kim SR; Jung SK
Food Funct; 2023 May; 14(10):4777-4791. PubMed ID: 37128780
[TBL] [Abstract][Full Text] [Related]
31. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
Ye X; Sun M
Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
[TBL] [Abstract][Full Text] [Related]
32. Andrographolide derivative AL-1 reduces intestinal permeability in dextran sulfate sodium (DSS)-induced mice colitis model.
Jiang N; Wei Y; Cen Y; Shan L; Zhang Z; Yu P; Wang Y; Xu L
Life Sci; 2020 Jan; 241():117164. PubMed ID: 31838135
[TBL] [Abstract][Full Text] [Related]
33. Protective role of tumor necrosis factor (TNF) receptors in chronic intestinal inflammation: TNFR1 ablation boosts systemic inflammatory response.
Wang Y; Han G; Chen Y; Wang K; Liu G; Wang R; Xiao H; Li X; Hou C; Shen B; Guo R; Li Y; Chen G
Lab Invest; 2013 Sep; 93(9):1024-35. PubMed ID: 23897411
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Use of Proton Pump Inhibitors Disrupts Intestinal Tight Junction Barrier and Exaggerates Experimental Colitis.
Nighot M; Liao PL; Morris N; McCarthy D; Dharmaprakash V; Ullah Khan I; Dalessio S; Saha K; Ganapathy AS; Wang A; Ding W; Yochum G; Koltun W; Nighot P; Ma T
J Crohns Colitis; 2023 Apr; 17(4):565-579. PubMed ID: 36322638
[TBL] [Abstract][Full Text] [Related]
35. Par-3 modulates intestinal epithelial barrier function through regulating intracellular trafficking of occludin and myosin light chain phosphorylation.
Yu M; Yang S; Qiu Y; Chen G; Wang W; Xu C; Cai W; Sun L; Xiao W; Yang H
J Gastroenterol; 2015 Nov; 50(11):1103-13. PubMed ID: 25820151
[TBL] [Abstract][Full Text] [Related]
36. Homoectoine Protects Against Colitis by Preventing a Claudin Switch in Epithelial Tight Junctions.
Castro-Ochoa KF; Vargas-Robles H; Chánez-Paredes S; Felipe-López A; Cabrera-Silva RI; Shibayama M; Betanzos A; Nava P; Galinski EA; Schnoor M
Dig Dis Sci; 2019 Feb; 64(2):409-420. PubMed ID: 30269272
[TBL] [Abstract][Full Text] [Related]
37. TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality.
Mizoguchi E; Hachiya Y; Kawada M; Nagatani K; Ogawa A; Sugimoto K; Mizoguchi A; Podolsky DK
Gastroenterology; 2008 Feb; 134(2):470-80. PubMed ID: 18242213
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK/pMLC signaling pathway in a piglet model.
Chang Y; Deng Q; Zhang Z; Zhao H; Tang J; Chen X; Liu G; Tian G; Cai J; Jia G
J Cell Physiol; 2021 Apr; 236(4):3015-3032. PubMed ID: 32960454
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR
Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232
[TBL] [Abstract][Full Text] [Related]
40. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo.
Clayburgh DR; Barrett TA; Tang Y; Meddings JB; Van Eldik LJ; Watterson DM; Clarke LL; Mrsny RJ; Turner JR
J Clin Invest; 2005 Oct; 115(10):2702-15. PubMed ID: 16184195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
